I hope the Bintai deal is still alive and hasn’t faded into obscurity like many other things in Generex history.

Now that 1st qtr is almost over it would be great to hear some solid updates on other Generex plans. Has Excellegan restarted their VA efforts? Can’t remember, but I believe the Regentys trial that was originally scheduled for late 2019 (per a past PR) should be starting soon. Telemedicine...where are they with that?